Mineralys Therapeutics Inc banner
M

Mineralys Therapeutics Inc
NASDAQ:MLYS

Watchlist Manager
Mineralys Therapeutics Inc
NASDAQ:MLYS
Watchlist
Price: 27.97 USD -1.62% Market Closed
Market Cap: $2.2B

Cash Flow Statement

Cash Flow Statement
Mineralys Therapeutics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
(30)
(42)
(55)
(57)
(72)
(91)
(120)
(153)
(178)
(189)
(191)
(171)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
Stock-Based Compensation
0
1
2
4
5
7
8
10
11
13
14
17
Other Non-Cash Items
(0)
(0)
(1)
(1)
(2)
(2)
(1)
(0)
2
5
7
10
Change in Working Capital
1
1
(7)
(4)
(7)
6
24
25
10
(9)
(10)
(10)
Cash from Operating Activities
(29)
N/A
(42)
-44%
(62)
-49%
(62)
+0%
(81)
-30%
(87)
-7%
(97)
-11%
(128)
-32%
(166)
-30%
(193)
-16%
(193)
0%
(171)
+11%
Investing Cash Flow
Capital Expenditures
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
0
Other Items
(22)
(162)
(178)
(102)
(160)
(76)
(52)
24
115
78
27
(203)
Cash from Investing Activities
(22)
N/A
(162)
-645%
(178)
-10%
(102)
+43%
(160)
-57%
(76)
+53%
(52)
+32%
24
N/A
115
+384%
78
-32%
27
-65%
(203)
N/A
Financing Cash Flow
Net Issuance of Common Stock
130
333
333
203
203
115
116
116
117
190
200
495
Other
(2)
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Cash from Financing Activities
128
N/A
332
+159%
331
0%
202
-39%
203
+1%
115
-43%
116
+1%
116
0%
116
+0%
189
+63%
199
+5%
494
+148%
Change in Cash
Net Change in Cash
77
N/A
128
+66%
90
-29%
37
-59%
(38)
N/A
(48)
-24%
(32)
+32%
11
N/A
65
+470%
75
+15%
33
-55%
120
+259%
Free Cash Flow
Free Cash Flow
(29)
N/A
(42)
-44%
(62)
-49%
(62)
+0%
(81)
-30%
(87)
-8%
(97)
-11%
(128)
-32%
(166)
-30%
(193)
-16%
(193)
0%
(171)
+11%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett